Analyst Consensus ?
ConsensusHold23 ratings
Bullish1356.5%
Neutral939.1%
Bearish14.4%
FN2 Earnings Intelligence
IDEXX Laboratories, Inc. analyst ratings
IDEXX Laboratories, Inc. (IDXX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$504.7Current
$247Low
$637.65Average
$830High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 13, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Aug 11, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Stifel | Buy | Buy | Maintain | Mar 31, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Feb 9, 2026 |
| BTIG | Buy | Buy | Maintain | Feb 3, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Nov 4, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Nov 4, 2025 |
| Leerink Partners | Outperform | Outperform | Maintain | Jul 17, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 21, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jan 17, 2024 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Aug 2, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 13, 2021 |
| Guggenheim | Neutral | Buy | Downgrade | Jul 12, 2021 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 22, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | May 2, 2019 |
| Bank of America | Buy | Buy | Maintain | Nov 2, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jan 16, 2018 |
| Aegis Capital | Sell | Sell | Maintain | Jun 1, 2017 |
| CL King | Neutral | Neutral | Maintain | Apr 1, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Aug 28, 2015 |
| Feltl & Co. | Hold | Sell | Upgrade | Jul 23, 2015 |
| Bank oferica | Buy | Buy | Maintain | Apr 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $504.7. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Glen Santangelo | $710 | $595.76 | +40.7% | Aug 11, 2026 |
| UBS | Analyst unavailable | $620 | $559.86 | +22.8% | Jul 27, 2026 |
| UBS | Andrea Alfonso | $640 | $569.17 | +26.8% | Apr 28, 2026 |
| Piper Sandler | Analyst unavailable | $750 | $644.61 | +48.6% | Feb 9, 2026 |
| Barclays | Glen Santangelo | $800 | $642.94 | +58.5% | Feb 5, 2026 |
| UBS | Andrea Alfonso | $730 | $639.6 | +44.6% | Feb 3, 2026 |
| BTIG | Analyst unavailable | $800 | $639.6 | +58.5% | Feb 3, 2026 |
| Barclays | Glen Santangelo | $850 | $706.65 | +68.4% | Dec 8, 2025 |
| Morgan Stanley | Analyst unavailable | $805 | $721.04 | +59.5% | Nov 4, 2025 |
| UBS | Analyst unavailable | $750 | $722.94 | +48.6% | Nov 4, 2025 |
| BTIG | Analyst unavailable | $830 | $722.94 | +64.5% | Nov 4, 2025 |
| Jefferies | Keith Devas | $830 | $722.94 | +64.5% | Nov 4, 2025 |
| Leerink Partners | Analyst unavailable | $785 | $722.94 | +55.5% | Nov 3, 2025 |
| Stifel Nicolaus | Jonathan Block | $775 | $722.94 | +53.6% | Nov 3, 2025 |
| Stifel Nicolaus | Jonathan Block | $700 | $628.54 | +38.7% | Oct 31, 2025 |
| UBS | Andrea Alfonso | $720 | $638.89 | +42.7% | Oct 1, 2025 |
| Morgan Stanley | Analyst unavailable | $722 | $641.94 | +43.1% | Aug 5, 2025 |
| BTIG | Analyst unavailable | $785 | $641.94 | +55.5% | Aug 5, 2025 |
| Stifel Nicolaus | Analyst unavailable | $640 | $682.78 | +26.8% | Aug 4, 2025 |
| Stifel Nicolaus | Jonathan Block | $510 | $495.73 | +1.1% | Jun 24, 2024 |
| Barclays | Analyst unavailable | $590 | $507.68 | +16.9% | Feb 8, 2023 |
| J.P. Morgan | Analyst unavailable | $550 | $487.04 | +9.0% | Feb 7, 2023 |
| Atlantic Equities | Analyst unavailable | $600 | $485.53 | +18.9% | Feb 7, 2023 |
| Oppenheimer | Analyst unavailable | $247 | $483.2 | -51.1% | Feb 2, 2023 |
| Citigroup | Analyst unavailable | $268 | $483.2 | -46.9% | Feb 2, 2023 |
| Citigroup | Analyst unavailable | $273 | $420.63 | -45.9% | Dec 9, 2022 |
| Morgan Stanley | Analyst unavailable | $543 | $435.78 | +7.6% | Nov 15, 2022 |
| Stifel Nicolaus | Analyst unavailable | $500 | $355.62 | -0.9% | Jun 24, 2022 |
| Goldman Sachs | Analyst unavailable | $530 | $357.33 | +5.0% | May 19, 2022 |
| Barclays | Balaji Prasad | $700 | $364.5 | +38.7% | May 6, 2022 |
Track every rating change on IDXX the moment it posts. Free to start.
Start free